Skip to content
Society

Patient Organizations Launch Free BRCA Gene Testing Program for Cancer Patients

News Hong Kong Editorial team · AI-written, reviewed under our editorial standards · · Reading time 9min read · Views 0 ·
Key — Patient organizations launched a free BRCA gene testing subsidy program for eligible breast and prostate cancer patients in Hong Kong and Macau.

Patient organizations have partnered with a gene testing company to launch a free BRCA gene testing subsidy program across Hong Kong and Macau. This new initiative offers free BRCA1/2 gene testing for eligible breast and prostate cancer patients across both jurisdictions. The testing aims to enable early detection, early treatment, improved efficacy, and delayed recurrence for high-risk cancer patients. The program is currently accepting applications on a first-come, first-served basis across both territories. The subsidy covers the full cost of BRCA1/2 gene testing and professional genetic counseling services for participants. Each patient is eligible for only one test under this subsidy program. This program is designed to leverage genomic sequencing to improve survival rates and delay recurrence for high-risk cancer patients.

Program Eligibility and Scope

The program applies to three specific patient groups across Hong Kong and Macau. These groups include HR-positive/HER2-negative breast cancer patients, triple-negative breast cancer patients, and metastatic prostate cancer patients. Eligible applicants must possess a valid Hong Kong or Macau identity card to participate in the testing subsidy. Applicants must also be patients of hospitals under the Hong Kong Hospital Authority, Macau public hospitals, or private medical groups. A doctor's referral form is required for all applicants to submit for consideration. Fang Jia-yi, Chairman of the Cancer Information Network Charity Fund, urged individuals with family medical histories to undergo early testing to protect their own and family health. The program is designed to leverage genomic sequencing to improve survival rates and delay recurrence for high-risk cancer patients.

Clinical Risk Factors

Clinical oncologists provided specific risk statistics regarding BRCA mutations. Dr. Lu Chuan-chan, a clinical oncologist, stated that BRCA1 mutation carriers have a 55% to 65% risk of breast cancer before age 70. The same clinical oncologist noted that BRCA2 mutation carriers have a 45% risk of breast cancer before age 70. Furthermore, the clinical oncologist stated that BRCA1 mutation carriers have a 4.5 times higher risk of prostate cancer compared to the general male population. Dr. Lu Chuan-chan stressed that BRCA testing is crucial for determining subsequent treatment options, such as PARP inhibitors. Rebecca, a patient diagnosed with breast cancer at age 45, shared her experience of receiving a BRCA1 mutation diagnosis. The specific patient case study involving Rebecca, her mother, and aunt is reported only by Headline Daily.

Patient Experiences and Next Steps

She encouraged others to seek early detection and preparation based on her personal experience.

Glossary

  • BRCA — The British Radio Car Association (or BRCA) is an organisation that promotes the construction and racing of all types of radio controlled cars in the United Kingdom. They coordinate BRCA affiliated clubs in the UK, and offer insurance for any accidents that might occur.
  • BRCA1/2 — Interim procedure in women with BRCA1/2 mutations, enabling them to delay oophorectomy. BRCA1/2 mutation carriers are recommended salpingectomy at around the age of 40 to decrease their risk of ovarian cancer.
  • BRCA1 — BRCA1 is another DNA-repair gene. Genes commonly found to be transcriptionally silenced due to promoter hypermethylation include: Cyclin-dependent kinase inhibitor p16, a cell-cycle inhibitor; MGMT, a DNA repair gene; APC, a cell cycle regulator; MLH1, a DNA-repair gene; and BRCA1, another DNA-repair gene.
  • triple-negative breast cancer — Breast cancer is a cancer that starts in breast tissue. It happens when cells in the breast change and grow out of control. These extra cells can form a mass called a tumor.
  • metastatic prostate cancer — Advanced prostate tumors can metastasize to nearby lymph nodes and bones, particularly in the pelvis, hips, spine, ribs, head, and neck. Bone metastases – present in around 85% of those with metastatic prostate cancer – are the primary cause of symptoms and death from metastatic prostate cancer.

This article was written with AI assistance from multiple news reports and is reviewed by our editors under our editorial principles. Editorial Standards · Tips & Contact

How did you like this post?

Comments 0

Be the first to comment

Contact us

← News Hong Kong Home
News Hong Kong Get new posts by emailSubscribe to receive new content via email. Unsubscribe anytime.
Was this helpful?Share it with friends & social